Literature DB >> 33501949

One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.

Lei Zhou1, Zunyou Wu1, Zhongjie Li1, Yanping Zhang1, Jennifer M McGoogan1, Qun Li1, Xiaoping Dong1, Ruiqi Ren1, Luzhao Feng1, Xiaopeng Qi1, Jingjing Xi1, Ying Cui1, Wenjie Tan1, Guoqing Shi1, Guizhen Wu1, Wenbo Xu1, Xiaoqi Wang1, Jiaqi Ma1, Xuemei Su1, Zijian Feng1, George F Gao1.   

Abstract

The epidemic of novel coronavirus disease was first reported in China in late December 2019 and was brought under control after some 2 months in China. However, it has become a global pandemic, and the number of cases and deaths continues to increase outside of China. We describe the emergence of the pandemic, detail the first 100 days of China's response as a phase 1 containment strategy followed by phase 2 containment, and briefly highlight areas of focus for the future. Specific, simple, and pragmatic strategies used in China for risk assessment, prioritization, and deployment of resources are described. Details of implementation, at different risk levels, of the traditional public health interventions are shared. Involvement of society in mounting a whole country response and challenges experienced with logistics and supply chains are described. Finally, the methods China is employing to cautiously restart social life and economic activity are outlined.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  2019-nCoV; SARS-CoV-2; novel coronavirus pneumonia; pandemic; response

Mesh:

Year:  2021        PMID: 33501949      PMCID: PMC7314211          DOI: 10.1093/cid/ciaa725

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  19 in total

1.  Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020.

Authors:  Ruiqi Ren; Yanping Zhang; Qun Li; Jennifer M McGoogan; Zijian Feng; George F Gao; Zunyou Wu
Journal:  JAMA       Date:  2021-02-02       Impact factor: 56.272

2.  Household quarantine of second degree contacts is an effective non-pharmaceutical intervention to prevent tertiary cases in the current SARS-CoV pandemic.

Authors:  Josef A I Weigl; Anna-Katharina Feddersen; Mona Stern
Journal:  BMC Infect Dis       Date:  2021-12-19       Impact factor: 3.090

3.  The re-emergence from the COVID-19 epidemic of Beijing Xinfadi Market.

Authors:  Haiqian Chen; Leiyu Shi; Yuyao Zhang; Xiaohan Wang; Gang Sun
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

4.  Coronavirus disease 2019 outbreak in Beijing's Xinfadi Market, China: a modeling study to inform future resurgence response.

Authors:  Xiao-Li Wang; Xin Lin; Peng Yang; Zun-You Wu; Gang Li; Jennifer M McGoogan; Zeng-Tao Jiao; Xin-Jun He; Si-Qi Li; Hong-Hao Shi; Jing-Yuan Wang; Sheng-Jie Lai; Chun Huang; Quan-Yi Wang
Journal:  Infect Dis Poverty       Date:  2021-05-07       Impact factor: 4.520

5.  Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China.

Authors:  Zhongjie Li; Xuhua Guan; Naiying Mao; Huiming Luo; Ying Qin; Na He; Zhen Zhu; Jianxing Yu; Yu Li; Jianhua Liu; Zhijie An; Wenjing Gao; Xiaoli Wang; Xiaodong Sun; Tie Song; Xingfen Yang; Ming Wu; Xianping Wu; Wenqing Yao; Zhibin Peng; Junling Sun; Liping Wang; Qing Guo; Nijuan Xiang; Jun Liu; Bike Zhang; Xuemei Su; Lance Rodewald; Liming Li; Wenbo Xu; Hongbing Shen; Zijian Feng; George F Gao
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05

6.  Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China.

Authors:  Xia Li; Qin Wang; Pei Ding; Yu'e Cha; Yixin Mao; Cheng Ding; Wen Gu; Youbin Wang; Bo Ying; Xiaoning Zhao; Lijun Pan; Yunpu Li; Junrui Chang; Congshen Meng; Jun Zhou; Zhigang Tang; Ruofeng Sun; Fuchang Deng; Chong Wang; Li Li; Jiao Wang; C Raina MacIntyre; Zunyou Wu; Zijian Feng; Song Tang; Dongqun Xu
Journal:  Sci Total Environ       Date:  2021-03-02       Impact factor: 7.963

7.  Strengthening public health at the community-level in China.

Authors:  Zhongjie Li; George F Gao
Journal:  Lancet Public Health       Date:  2020-12

Review 8.  A review of deep learning-based detection methods for COVID-19.

Authors:  Nandhini Subramanian; Omar Elharrouss; Somaya Al-Maadeed; Muhammed Chowdhury
Journal:  Comput Biol Med       Date:  2022-01-29       Impact factor: 4.589

9.  Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS.

Authors:  Jiajia Li; Shixue Li; Wuchun Cao; Zhongli Wang; Zhuohui Liang; Wenhao Fu; Jinfeng Zhao
Journal:  Front Public Health       Date:  2021-07-07

10.  Risk Factors for Death Among the First 80 543 Coronavirus Disease 2019 (COVID-19) Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region.

Authors:  Yanping Zhang; Wei Luo; Qun Li; Xijie Wang; Jin Chen; Qinfeng Song; Hong Tu; Ruiqi Ren; Chao Li; Dan Li; Jing Zhao; Jennifer M McGoogan; Duo Shan; Bing Li; Jingxue Zhang; Yanhui Dong; Yu Jin; Shuai Mao; Menbao Qian; Chao Lv; Huihui Zhu; Limin Wang; Lin Xiao; Juan Xu; Dapeng Yin; Lei Zhou; Zhongjie Li; Guoqing Shi; Xiaoping Dong; Xuhua Guan; George F Gao; Zunyou Wu; Zijian Feng
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.